Andrea Hunt
Director/Board Member at OX2 Therapeutics, Inc.
Net worth: - $ as of 2024-04-29
Profile
Andrea S.
Hunt is currently the Director at OX2 Therapeutics, Inc. and also holds the position of Treasurer & Director at Safe Place & Rape Crisis Center, Inc. She has previously worked as a Director at Make-A-Wish Foundation of Illinois, Director at Alliance for Regenerative Medicine, Independent Director at Catalyst Biosciences, Inc., Director at Ryan Banks Academy, Vice President-Lead BAX855 & Gene Therapy at Baxter Healthcare Corp., VP-New Product Gene Therapy & Neuroscience at Shire Plc, and VP-Global Franchise & Head-Blood Disorders at Baxalta, Inc. Ms. Hunt holds an MBA degree from the University of Michigan and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
-.--% | 2023-08-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Andrea Hunt active positions
Companies | Position | Start |
---|---|---|
OX2 Therapeutics, Inc.
OX2 Therapeutics, Inc. Hospital/Nursing ManagementHealth Services OX2 Therapeutics, Inc. provides treatment of primary brain tumors and other central nervous system tumors. The company was founded by Michael Olin, Christopher L. Moertel and Sumant Dhawan in 2016 and is headquartered in Minneapolis, MN. | Director/Board Member | 2017-10-31 |
Safe Place & Rape Crisis Center, Inc. | Director/Board Member | - |
Former positions of Andrea Hunt
Companies | Position | End |
---|---|---|
CATALYST BIOSCIENCES | Director/Board Member | 2023-10-29 |
SHIRE | Corporate Officer/Principal | 2017-05-31 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 2016-12-31 |
BAXALTA INC | Corporate Officer/Principal | 2016-05-31 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 2015-05-31 |
Training of Andrea Hunt
University of Michigan | Masters Business Admin |
University of Illinois At Urbana–Champaign | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 9 |
---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Make-A-Wish Foundation of Illinois | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
OX2 Therapeutics, Inc.
OX2 Therapeutics, Inc. Hospital/Nursing ManagementHealth Services OX2 Therapeutics, Inc. provides treatment of primary brain tumors and other central nervous system tumors. The company was founded by Michael Olin, Christopher L. Moertel and Sumant Dhawan in 2016 and is headquartered in Minneapolis, MN. | Health Services |
Ryan Banks Academy | |
Safe Place & Rape Crisis Center, Inc. |
- Stock Market
- Insiders
- Andrea Hunt